Bictegravir, emtricitabine, and tenofovir and Golimumab Subcutaneous
Determining the interaction of Bictegravir, emtricitabine, and tenofovir and Golimumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bictegravir / emtricitabine / tenofovir alafenamide
Brand name: Biktarvy
Synonyms: Bictegravir, Emtricitabine, and Tenofovir Alafenamide
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bictegravir, emtricitabine, and tenofovir-GoLYTELY
- Bictegravir, emtricitabine, and tenofovir-Gonadorelin
- Bictegravir, emtricitabine, and tenofovir-Gonadorelin Intravenous, Injection
- Bictegravir, emtricitabine, and tenofovir-Gonadotropin, Chorionic
- Bictegravir, emtricitabine, and tenofovir-Gonal-F
- Bictegravir, emtricitabine, and tenofovir-Gonal-f RFF
- Golimumab Subcutaneous-Bictegravir, Emtricitabine, and Tenofovir Alafenamide
- Golimumab Subcutaneous-Bidex-A
- Golimumab Subcutaneous-BiDil
- Golimumab Subcutaneous-Bifera
- Golimumab Subcutaneous-BiferaRx
- Golimumab Subcutaneous-Bijuva